Literature DB >> 18224252

Involvement of the p38 MAPK-NF-kappaB signal transduction pathway and COX-2 in the pathobiology of meniscus degeneration in humans.

Dionysios J Papachristou1, Eugenia Papadakou, Efthimia K Basdra, Panagiotis Baltopoulos, Elias Panagiotopoulos, Athanasios G Papavassiliou.   

Abstract

Meniscal tears are attributed to either trauma or degeneration processes. Clinical data suggest that meniscal degeneration (MD) is associated with knee osteoarthritis; however, the molecular events underpinning the pathogenesis of MD in humans remain elusive. Here we immunohistochemically examined the expression of p38 MAPK, its phosphorylated/activated form (p-p38), its target NF-kappaB (p50-p65 dimer), and COX-2 in ruptured menisci and investigated their involvement in MD development. Our findings demonstrate increased expression of the p38-NF-kappaB axis elements and COX-2 in disintegrated fibrocartilage, suggesting a role of these molecules in the pathobiochemistry of MD and consequential rupture.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18224252      PMCID: PMC2213893          DOI: 10.2119/2007-00138.Papachristou

Source DB:  PubMed          Journal:  Mol Med        ISSN: 1076-1551            Impact factor:   6.354


  34 in total

Review 1.  Rheumatoid arthritis. Pathophysiology and implications for therapy.

Authors:  E D Harris
Journal:  N Engl J Med       Date:  1990-05-03       Impact factor: 91.245

Review 2.  NFkappaB pathway: a good signaling paradigm and therapeutic target.

Authors:  Vinay Tergaonkar
Journal:  Int J Biochem Cell Biol       Date:  2006       Impact factor: 5.085

Review 3.  Molecular mechanisms of cartilage destruction: mechanics, inflammatory mediators, and aging collide.

Authors:  Richard F Loeser
Journal:  Arthritis Rheum       Date:  2006-05

4.  The MAPK-AP-1/-Runx2 signalling axes are implicated in chondrosarcoma pathobiology either independently or via up-regulation of VEGF.

Authors:  D J Papachristou; G I Papachristou; G J Papachristou; O A Papaefthimiou; N J Agnantis; E K Basdra; A G Papavassiliou
Journal:  Histopathology       Date:  2005-12       Impact factor: 5.087

5.  Degenerative meniscus tears and mobility impairment in women with knee osteoarthritis.

Authors:  A K Lange; M A Fiatarone Singh; R M Smith; N Foroughi; M K Baker; R Shnier; B Vanwanseele
Journal:  Osteoarthritis Cartilage       Date:  2007-01-03       Impact factor: 6.576

Review 6.  Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases.

Authors:  P J Barnes; M Karin
Journal:  N Engl J Med       Date:  1997-04-10       Impact factor: 91.245

Review 7.  NF-kappa B and Rel: participants in a multiform transcriptional regulatory system.

Authors:  M Grilli; J J Chiu; M J Lenardo
Journal:  Int Rev Cytol       Date:  1993

Review 8.  Signalling networks regulating cyclooxygenase-2.

Authors:  Christos Tsatsanis; Ariadne Androulidaki; Maria Venihaki; Andrew N Margioris
Journal:  Int J Biochem Cell Biol       Date:  2006-04-25       Impact factor: 5.085

9.  Pathologic characteristics of the torn human meniscus.

Authors:  Mena Mesiha; David Zurakowski; Jamil Soriano; Jason H Nielson; Bertram Zarins; Martha M Murray
Journal:  Am J Sports Med       Date:  2006-11-07       Impact factor: 6.202

10.  The effect of aging and osteoarthritis on the mature and senescent cross-links of collagen in human meniscus.

Authors:  M Takahashi; M Suzuki; K Kushida; H Hoshino; T Inoue
Journal:  Arthroscopy       Date:  1998 May-Jun       Impact factor: 4.772

View more
  13 in total

Review 1.  Mitogen-activated protein kinases as therapeutic targets in osteoarthritis.

Authors:  Richard F Loeser; Elizabeth A Erickson; David L Long
Journal:  Curr Opin Rheumatol       Date:  2008-09       Impact factor: 5.006

Review 2.  [Histopathological meniscus diagnostic].

Authors:  A Fisseler-Eckhoff; K-M Müller
Journal:  Orthopade       Date:  2009-06       Impact factor: 1.087

3.  [Histopathological evaluation of the meniscus].

Authors:  A Fisseler-Eckhoff; K-M Müller
Journal:  Pathologe       Date:  2011-05       Impact factor: 1.011

4.  Continuous hydrostatic pressure induces differentiation phenomena in chondrocytes mediated by changes in polycystins, SOX9, and RUNX2.

Authors:  Konstantinos Karamesinis; Anastasia Spyropoulou; Georgia Dalagiorgou; Maria A Katsianou; Marjan Nokhbehsaim; Svenja Memmert; James Deschner; Heleni Vastardis; Christina Piperi
Journal:  J Orofac Orthop       Date:  2016-12-01       Impact factor: 1.938

5.  Pro-inflammatory stimulation of meniscus cells increases production of matrix metalloproteinases and additional catabolic factors involved in osteoarthritis pathogenesis.

Authors:  A V Stone; R F Loeser; K S Vanderman; D L Long; S C Clark; C M Ferguson
Journal:  Osteoarthritis Cartilage       Date:  2013-12-04       Impact factor: 6.576

6.  Inflammatory effect of advanced glycation end products on human meniscal cells from osteoarthritic knees.

Authors:  Hideki Hiraiwa; Tadahiro Sakai; Hirohito Mitsuyama; Takashi Hamada; Ryuichiro Yamamoto; Takaaki Omachi; Yohei Ohno; Motoshige Nakashima; Naoki Ishiguro
Journal:  Inflamm Res       Date:  2011-08-13       Impact factor: 4.575

7.  Reduced response of human meniscal cells to Osteogenic Protein 1 during osteoarthritis and pro-inflammatory stimulation.

Authors:  K S Vanderman; R F Loeser; S Chubinskaya; A Anderson; C M Ferguson
Journal:  Osteoarthritis Cartilage       Date:  2016-01-08       Impact factor: 6.576

8.  Wortmannin, PI3K/Akt signaling pathway inhibitor, attenuates thyroid injury associated with severe acute pancreatitis in rats.

Authors:  Ablikim Abliz; Wenhong Deng; Rongze Sun; Wenyi Guo; Liang Zhao; Weixing Wang
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01

9.  Lubricin Distribution in the Menisci and Labra of Human Osteoarthritic Joints.

Authors:  Dafang Zhang; Thomas Cheriyan; Scott D Martin; Thomas M Schmid; Myron Spector
Journal:  Cartilage       Date:  2012-04       Impact factor: 4.634

10.  Severity of pancreatitis‑associated intestinal mucosal barrier injury is reduced following treatment with the NADPH oxidase inhibitor apocynin.

Authors:  Wenhong Deng; Ablikim Abliz; Sheng Xu; Rongze Sun; Wenyi Guo; Qiao Shi; Jia Yu; Weixing Wang
Journal:  Mol Med Rep       Date:  2016-08-26       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.